Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway
Acta Biochimica Polonica · 25.02.2021
DOI: 10.18388/abp.2020_5473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica Polonica, online erschienen am 25.02.2021. Verfasst von Zheming Shao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhejiang Sian Internatinal Hospital, Jiaxing City, Zhejiang Province, 314000, China. Hauptthemen laut MEDLINE: Cardiotonic Agents, Dexmedetomidine, Myocardial Reperfusion Injury, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Acute myocardial infarction (AMI) is a heart disease that seriously threatens human health. Dexmedetomidine (DEX) has a certain protective effect on cardiac injury. This study investigated the cardioprotective effect of DEX and its potential molecular mechanism in vivo and in vitro. The results showed that DEX could significantly increase the viability of hypoxia/reoxygenation (H/R) treated cardiomyocytes and reduce oxidative damage and apoptosis. Further molecular mechanism analysis showed that the above cardiac protective effects may be related to Akt signaling pathway. In addition, the expression of G-Protein Receptor 30 (GPR30) was promoted after H/R treatment. However, knockdown of GPR30 by shRNA significantly counteracted the cardioprotective effect of DEX. Meanwhile, we constructed a rat model of AMI to investigate the role of GPR30 in vivo. The results showed that DEX significantly reduced the infarct size, and GPR30 agonist G1 enhanced the protective effect of DEX on heart. On the contrary, protein kinase B (AKT) inhibitor LY294002 counteracted the protective effect of DEX on heart, suggesting that GPR30 enhanced the protective effect of DEX on ischemia-reperfusion induced heart injury by regulating AKT related pathways. In conclusion, our study provides a potential target for the clinical treatment of AMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Zhejiang Sian Internatinal Hospital, Jiaxing City, Zhejiang Province, 314000, China.
- Department of Anesthesiology-Jiaxing Key Discipline of Medicine-Anesthesiology (2019-zc-06), The Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing City, Zhejiang Province, 314001, China.
Zitieren
APA
Shao, Z., Shen, Q., Kong, M., Ni, H., & Hou, X. (2021). Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway. Acta Biochimica Polonica. https://doi.org/10.18388/abp.2020_5473
Vancouver
Shao Z, Shen Q, Kong M, Ni H, Hou X. Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway. Acta Biochimica Polonica. 2021. doi:10.18388/abp.2020_5473
BibTeX
@article{Shao2021,
author = {Shao, Zheming and Shen, Qihong and Kong, Min and Ni, Huadong and Hou, Xiaomin},
title = {Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway},
journal = {Acta Biochimica Polonica},
year = {2021},
doi = {10.18388/abp.2020_5473}
}
EUVIMED